EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit

NEW YORK, Jan. 28, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025.So what: If you purchased ESSA Pharma Inc. securities during ...